baclofen has been researched along with Nervous System Diseases in 19 studies
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "OBJECTIVE Intrathecal baclofen infusion systems to manage severe spasticity and dystonia are associated with higher infection rates in children than in adults." | 7.83 | Risk factors for baclofen pump infection in children: a multivariate analysis. ( Bollo, RJ; Bowers, CA; Riva-Cambrin, J; Spader, HS, 2016) |
| "Intrathecal baclofen (ITB) treatment is applied in patients with spastic cerebral palsy (SCP), dystonic cerebral palsy (DCP) and progressive neurological disease (PND)." | 7.83 | The effect of intrathecal baclofen treatment on activities of daily life in children and young adults with cerebral palsy and progressive neurological disorders. ( Becher, J; Bonouvrié, L; Buizer, A; Soudant, D; van Ouwerkerk, W; Vermeulen, RJ; Vles, G, 2016) |
| "OBJECTIVE Intrathecal baclofen infusion systems to manage severe spasticity and dystonia are associated with higher infection rates in children than in adults." | 3.83 | Risk factors for baclofen pump infection in children: a multivariate analysis. ( Bollo, RJ; Bowers, CA; Riva-Cambrin, J; Spader, HS, 2016) |
| "Intrathecal baclofen (ITB) treatment is applied in patients with spastic cerebral palsy (SCP), dystonic cerebral palsy (DCP) and progressive neurological disease (PND)." | 3.83 | The effect of intrathecal baclofen treatment on activities of daily life in children and young adults with cerebral palsy and progressive neurological disorders. ( Becher, J; Bonouvrié, L; Buizer, A; Soudant, D; van Ouwerkerk, W; Vermeulen, RJ; Vles, G, 2016) |
| "Treating severe spasticity with the continuous infusion of intrathecal baclofen through an implantable delivery system is a new and successful alternative to oral medications and ablative surgical procedures." | 2.38 | Intrathecal baclofen for spinal spasticity: implications for nursing practice. ( Gianino, J, 1993) |
| "They have been of value in treating pain of cancer and spasticity through spinal subarachnoid catheters." | 2.37 | Drug pumps for treatment of neurologic diseases and pain. ( Penn, RD, 1985) |
| "Baclofen is the treatment of choice for spasticity and is usually given in doses of 30 to 80 mg/day, although higher doses may be used." | 2.37 | Multiple sclerosis. Current concepts in management. ( Giesser, B, 1985) |
| "In the alcohol dependence group, median duration of baclofen treatment was 143." | 1.40 | Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns--a cohort study. ( Dupouy, J; Fournier, JP; Jouanjus, É; Lapeyre-Mestre, M; Oustric, S; Palmaro, A; Poutrain, JC, 2014) |
| "In ambulatory patients with spasticity, it is possible that ITB treatment may compromise ambulatory function by unmasking underlying muscle weakness." | 1.33 | Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. ( Sadiq, SA; Wang, GC, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonouvrie, L | 2 |
| Revol, B | 1 |
| Jullian-Desayes, I | 1 |
| Bailly, S | 1 |
| Mallaret, M | 1 |
| Tamisier, R | 1 |
| Agier, MS | 1 |
| Lador, F | 1 |
| Joyeux-Faure, M | 1 |
| Pépin, JL | 1 |
| Dupouy, J | 1 |
| Fournier, JP | 1 |
| Jouanjus, É | 1 |
| Palmaro, A | 1 |
| Poutrain, JC | 1 |
| Oustric, S | 1 |
| Lapeyre-Mestre, M | 1 |
| Spader, HS | 1 |
| Bollo, RJ | 1 |
| Bowers, CA | 1 |
| Riva-Cambrin, J | 1 |
| Becher, J | 1 |
| Soudant, D | 1 |
| Buizer, A | 1 |
| van Ouwerkerk, W | 1 |
| Vles, G | 1 |
| Vermeulen, RJ | 2 |
| Richter, E | 1 |
| Baldovini, A | 1 |
| Blasco, V | 1 |
| Leone, M | 1 |
| Albanese, J | 1 |
| Tanaka, K | 1 |
| Bonouvrié, LA | 1 |
| van Schie, PE | 1 |
| Becher, JG | 1 |
| van Ouwerkerk, WJ | 1 |
| Nebbioso, M | 1 |
| D'Innocenzo, D | 1 |
| Rapone, S | 1 |
| Di Benedetto, G | 1 |
| Grenga, R | 1 |
| Sadiq, SA | 1 |
| Wang, GC | 1 |
| Panourias, IG | 1 |
| Themistocleous, M | 1 |
| Sakas, DE | 1 |
| Stevenson, VL | 1 |
| Seyfert, S | 1 |
| Straschill, M | 1 |
| Smith, GD | 1 |
| Harrison, SM | 1 |
| Birch, PJ | 1 |
| Elliott, PJ | 1 |
| Malcangio, M | 1 |
| Bowery, NG | 1 |
| Gianino, J | 1 |
| Peng, CT | 1 |
| Ger, J | 1 |
| Yang, CC | 1 |
| Tsai, WJ | 1 |
| Deng, JF | 1 |
| Bullard, MJ | 1 |
| Penn, RD | 1 |
| Giesser, B | 1 |
| Greene, P | 1 |
| Shale, H | 1 |
| Fahn, S | 1 |
6 reviews available for baclofen and Nervous System Diseases
| Article | Year |
|---|---|
[Nystagmus in ophthalmology].
Topics: Amines; Baclofen; Cyclohexanecarboxylic Acids; Diagnostic Techniques, Ophthalmological; Eye Diseases | 2009 |
Intrathecal baclofen in current neuromodulatory practice: established indications and emerging applications.
Topics: Baclofen; Electric Stimulation Therapy; Electrodes, Implanted; Humans; Muscle Relaxants, Central; Mu | 2007 |
Relief of symptoms in end-stage neurological conditions.
Topics: Baclofen; Clinical Trials, Phase I as Topic; Cognition Disorders; Deglutition Disorders; Humans; Moo | 2007 |
Intrathecal baclofen for spinal spasticity: implications for nursing practice.
Topics: Baclofen; Humans; Infusion Pumps, Implantable; Injections, Spinal; Long-Term Care; Muscle Spasticity | 1993 |
Drug pumps for treatment of neurologic diseases and pain.
Topics: Alzheimer Disease; Baclofen; Bethanechol; Bethanechol Compounds; Catheters, Indwelling; Chronic Dise | 1985 |
Multiple sclerosis. Current concepts in management.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Baclofen; Dantrolene; Fatigue; Gastrointestina | 1985 |
13 other studies available for baclofen and Nervous System Diseases
| Article | Year |
|---|---|
Intrathecal baclofen in progressive neurological disease: To be considered before all other options fail.
Topics: Baclofen; Humans; Infusion Pumps, Implantable; Injections, Spinal; Muscle Relaxants, Central; Muscle | 2018 |
Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database.
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Alcoholism; Apnea; Baclofen; Database | 2018 |
Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns--a cohort study.
Topics: Alcoholism; Baclofen; Dantrolene; Europe; Female; France; Hospitalization; Humans; Incidence; Male; | 2014 |
Risk factors for baclofen pump infection in children: a multivariate analysis.
Topics: Adolescent; Baclofen; Body Mass Index; Child; Child, Preschool; Cohort Studies; Drug Delivery System | 2016 |
The effect of intrathecal baclofen treatment on activities of daily life in children and young adults with cerebral palsy and progressive neurological disorders.
Topics: Activities of Daily Living; Adolescent; Adult; Baclofen; Cerebral Palsy; Child; Cross-Sectional Stud | 2016 |
About baclofen withdrawal syndrome.
Topics: Adult; Baclofen; Female; GABA-B Receptor Agonists; Humans; Nervous System Diseases; Substance Withdr | 2016 |
[Usefulness of Bolus Administration Using the FLEX Mode(Bolus Infusion Mode)for Baclofen Tolerance].
Topics: Baclofen; Female; Humans; Injections, Spinal; Male; Middle Aged; Muscle Spasticity; Nervous System D | 2017 |
Satisfaction with intrathecal baclofen treatment in paediatric patients with progressive neurological disease.
Topics: Baclofen; Child; Disease Progression; Humans; Injections, Spinal; Muscle Relaxants, Central; Nervous | 2008 |
Long-term intrathecal baclofen therapy in ambulatory patients with spasticity.
Topics: Adult; Aged; Baclofen; Disabled Persons; Female; Follow-Up Studies; Humans; Infusion Pumps, Implanta | 2006 |
[Electroencephalographic changes induced by baclofen].
Topics: Adult; Aged; Baclofen; Electroencephalography; Evoked Potentials; Female; Humans; Male; Middle Aged; | 1982 |
Increased sensitivity to the antinociceptive activity of (+/-)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia.
Topics: Analgesics; Animals; Autoradiography; Baclofen; Dose-Response Relationship, Drug; GABA-B Receptor Ag | 1994 |
Prolonged severe withdrawal symptoms after acute-on-chronic baclofen overdose.
Topics: Adult; Baclofen; Cardiovascular Diseases; Drug Overdose; Humans; Male; Muscle Relaxants, Central; Ne | 1998 |
Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia.
Topics: Age Factors; Baclofen; Clonazepam; Dystonia Musculorum Deformans; Humans; Nervous System Diseases; P | 1988 |